article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

Now, with 1.5mg of a balanced THC:CBD tincture twice daily, he’s giving presentations at work and actually enjoying social events again. He’s now able to attend his daughter’s school events without panic attacks. Traditional medications left him feeling like a zombie.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Veterans, members of the LGBTQIA community , and women are disproportionately impacted due to their positions of vulnerability to traumatic events, such as life-threatening violence or sexual assault. Methodological Concerns with Blinding A particular concern raised by the FDA is the lack of effective blinding in the clinical trials.

article thumbnail

Numinus Announces Clinical Trial Of Psilocybin-Assisted Psychotherapy

Cannabis Life Network

announced early this morning that it will undertake a clinical trial of psilocybin-assisted psychotherapy. The compassionate access clinical trial will enable the company to refine optimal protocols for the use of psilocybin-assisted psychotherapy for participants with a range of substance use disorders.

article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. . This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada.

article thumbnail

Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Cannabis Law Report

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Los Angeles, California. www.InvestorBrandNetwork.com. 310.299.1717 Office.